Business Description
Biocartis Group NV
ISIN : BE0974281132
Share Class Description:
FRA:8XB: Shs 144A/Reg SDescription
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -84.87 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biocartis Group NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 60.612 | ||
| EPS (TTM) (€) | -0.92 | ||
| Beta | 1.34 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0.2595 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.2595 - 0.2595 | ||
| Shares Outstanding (Mil) | 93.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biocartis Group NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biocartis Group NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biocartis Group NV Frequently Asked Questions
What is Biocartis Group NV(FRA:8XB)'s stock price today?
The current price of FRA:8XB is €0.26. The 52 week high of FRA:8XB is €0.26 and 52 week low is €0.26.
When is next earnings date of Biocartis Group NV(FRA:8XB)?
The next earnings date of Biocartis Group NV(FRA:8XB) is .
Does Biocartis Group NV(FRA:8XB) pay dividends? If so, how much?
Biocartis Group NV(FRA:8XB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers